Genetic repeat polymorphism in the regulating region of CYP2E1:: Frequency and relationship with enzymatic activity in alcoholics

被引:13
作者
Plee-Gautier, E
Foresto, F
Ferrara, R
Bodénez, P
Simon, B
Manno, M
Berthou, F
Lucas, D
机构
[1] Fac Med, Biochem Lab, Brest, France
[2] Univ Padua, Inst Occupat Med, I-35100 Padua, Italy
关键词
CYP2E1; genetic polymorphism; chlorzoxazone hydroxylation; polymerase chain reaction; alcoholics;
D O I
10.1097/00000374-200106000-00002
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Differences in the regulatory region of the CYP2E1 gene could be responsible for the interindividual variation in the cytochrome P-450 2E1 (CYP2E1) involved in ethanol oxidation. Recently, a polymorphic repeat sequence in the human gene was described between -2178 and -1945 base pairs. Its frequency seemed to vary among different ethnic populations, and it was suspected to be related to an increased inducibility to further ethanol intake. In the study reported here, the frequency of this polymorphism was investigated in a white French population. Its relationship with the previously described PstI/ RsaI or DraI CYP2E1 polymorphisms, alcoholism, alcoholic liver disease, and inducibility of CYP2E1 by ethanol was examined. Methods: The polymorphic region was characterized by polymerase chain reaction in 103 controls, 148 alcoholic subjects without liver diseases, and 98 others with liver cirrhosis. By using in vivo chlorzoxazone (CHZ) metabolism, CYP2E1 phenotype was assessed in 36 non-ethanol-induced subjects (17 controls and 19 withdrawn alcoholics) and in 14 ethanol-induced subjects (10 controls after ingestion of 0.8 g/kg ethanol and four alcoholics with 100 g of daily intake). This phenotype was expressed as the 6-hydroxy CHZ/CHZ ratio. Results: The rare allele frequency was found to be 1.58% in whites (n = 349). Neither significant association with alcoholism or alcoholic liver diseases, nor relationship with the PstI/RsaI polymorphism, was observed. But the DraI polymorphism was more frequent among the heterozygous subjects when compared with wild-type homozygous ones (p < 0.05). The CYP2E1 phenotype was similar in wild-type homozygotes and in heterozygotes at the constitutive level, as well as after induction with ethanol. Conclusions: Our data suggest that CYP2E1 repeat polymorphism does not seem to constitute a major factor for interindividual differences in CYP2E1 expression and susceptibility to alcohol-related disorders in whites.
引用
收藏
页码:800 / 804
页数:5
相关论文
共 23 条
[1]   BOTH CYTOCHROMES P450 2E1 AND 1A1 ARE INVOLVED IN THE METABOLISM OF CHLORZOXAZONE [J].
CARRIERE, V ;
GOASDUFF, T ;
RATANASAVANH, D ;
MOREL, F ;
GAUTIER, JC ;
GUILLOUZO, A ;
BEAUNE, P ;
BERTHOU, F .
CHEMICAL RESEARCH IN TOXICOLOGY, 1993, 6 (06) :852-857
[2]  
Dupont I, 1999, DRUG METAB DISPOS, V27, P322
[3]   ASSESSMENT OF CYTOCHROME P4502E1 INDUCTION IN ALCOHOLIC PATIENTS BY CHLORZOXAZONE PHARMACOKINETICS [J].
GIRRE, C ;
LUCAS, D ;
HISPARD, E ;
MENEZ, C ;
DALLY, S ;
MENEZ, JF .
BIOCHEMICAL PHARMACOLOGY, 1994, 47 (09) :1503-1508
[4]   OXIDATION OF TOXIC AND CARCINOGENIC CHEMICALS BY HUMAN CYTOCHROME-P-450 ENZYMES [J].
GUENGERICH, FP ;
SHIMADA, T .
CHEMICAL RESEARCH IN TOXICOLOGY, 1991, 4 (04) :391-407
[5]  
GUENGERICH FP, 1991, J PHARMACOL EXP THER, V256, P1189
[6]   GENETIC POLYMORPHISMS IN THE 5'-FLANKING REGION CHANGE TRANSCRIPTIONAL REGULATION OF THE HUMAN CYTOCHROME P450IIE1 GENE [J].
HAYASHI, S ;
WATANABE, J ;
KAWAJIRI, K .
JOURNAL OF BIOCHEMISTRY, 1991, 110 (04) :559-565
[7]  
Hu Y, 1997, MOL PHARMACOL, V51, P370
[8]   Structural and functional characterization of the 5′-flanking region of the rat and human cytochrome P450 2E1 genes:: Identification of a polymorphic repeat in the human gene [J].
Hu, Y ;
Hakkola, J ;
Oscarson, M ;
Ingelman-Sundberg, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 263 (02) :286-293
[9]   ETHANOL-INDUCIBLE CYTOCHROME P4502E1 - GENETIC-POLYMORPHISM, REGULATION, AND POSSIBLE ROLE IN THE ETIOLOGY OF ALCOHOL-INDUCED LIVER-DISEASE [J].
INGELMANSUNDBERG, M ;
JOHANSSON, I ;
YIN, H ;
TERELIUS, Y ;
ELIASSON, E ;
CLOT, P ;
ALBANO, E .
ALCOHOL, 1993, 10 (06) :447-452
[10]  
Kim RB, 1996, J PHARMACOL EXP THER, V279, P4